Dr. Lisa Cassis, UK’s vice president for research, oversees the university’s vast medical and nonmedical research efforts. On this episode of "Behind the Blue," she discusses the many areas UK's Office of Research is prioritizing, including greater diversity and inclusion, the increasing commitment to opportunities for undergraduate research, returning research efforts to higher capacity during the COVID-19 pandemic, and more.

The study suggests that localized inflammation in the lungs caused by COVID-19 may be responsible for the increased presence of blood clots in patients, and that the risk of thrombosis could persist after the infection clears.

Lovoria Williams, Ph.D., co-director of integrated special populations for the CCTS and associate professor in the College of Nursing, is collaborating with faith communities to address these health disparities among minority and medically underserved populations in both Appalachia and predominately African American communities in Lexington.

The National Science Foundation recently awarded a three-year, $1,163,869 grant to the University of Kentucky to develop new state-of-the-art metabolomics data analysis tools that will derive new data, knowledge and interpretation from the active metabolic state of organisms and ecosystems with broad biological and biomedical applications.

Jon Thorson and UK were recently awarded a prestigious Centers of Biomedical Research Excellence (COBRE) grant to study translational chemical biology from the National Institutes of General Medical Sciences, part of the National Institutes of Health. The $11.2 million grant will fund UK's Center of Biomedical Research Excellence in Pharmaceutical Research and Innovation.

Researchers at the University of Kentucky are working to understand how the pandemic has affected people’s wellbeing, and which groups may be particularly at risk for negative outcomes.

The nationwide study invites families of children between ages one and five to participate in a survey.

Through the National COVID Cohort Collaborative, clinical institutions affiliated with the National Institutes of Health’s Clinical and Translational Science Awards Program are partnering with National Center for Advancing Translational Science and the National Center for Data to Health to study COVID-19 and identify potential treatments and analytics tools.

Two CCTS directors co-wrote an op-ed about the dual pandemics of COVID-19 and systemic racism.

With the support of a pilot grant, UK College of Medicine researchers are using special antibodies made by alpacas, called nanobodies, to help understand the novel coronavirus and potentially develop a treatment that could protect people from being infected.